Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
J Neurooncol
; 165(1): 101-112, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37864646
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Glioblastoma
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
J Neurooncol
Year:
2023
Type:
Article
Affiliation country:
United States